![COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]](https://i2.wp.com/media.premiumtimesng.com/wp-content/files/2020/08/COVID-19-vaccine-vials-e1599566938402.png?fit=800%2C600&ssl=1)
South Korea is expected to mass-produce commercial COVID-19 antibody-based treatment later in September.
The deputy director of the Korea Centres for Disease Control and Prevention, Kwon Jun-wook, said this on Tuesday.
The country is currently analysing the results of phase 1 clinical trial of the antibody-based treatment, which was approved by the Ministry of Food and Drug Safety on July 17, and reviewing the phase 2, Kwon added.
As for blood plasma-based treatment, the health authorities skipped phase one of clinical trials, as the therapy itself is well-known and considered to be safe.
The country will start producing the blood plasma material for the phase 2 trial on Tuesday, while the supply of the substance will be completed in mid-October, Mr Kwon noted.
In total, clinical trials for 14 coronavirus treatments and two vaccines are currently underway in South Korea.
(Sputnik/NAN)
Support PREMIUM TIMES' journalism of integrity and credibility
Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.
By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.
TEXT AD: To advertise here . Call Willie +2347088095401...
![Gibril Massaquoi, alias Angel Gabriel (Attached ) [CAPTION: Gibril Massaquoi, alias Angel Gabriel, talks with his lawyer in Tampere, Finland from where he is listening to the hearing in his war crimes trial in Liberia via videolink. Leslie Lumeh/New Narratives]](https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2021/03/image1-3.jpg?resize=120%2C86&ssl=1)
Discussion about this post